Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.

Horrigan SK, Arbieva ZH, Xie HY, Kravarusic J, Fulton NC, Naik H, Le TT, Westbrook CA.

Blood. 2000 Apr 1;95(7):2372-7.

2.
3.

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.

Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT.

Nat Med. 2007 Jan;13(1):78-83. Epub 2006 Dec 10.

PMID:
17159988
4.

C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.

Koike M, Chumakov AM, Takeuchi S, Tasaka T, Yang R, Nakamaki T, Tsuruoka N, Koeffler HP.

Leuk Res. 1997 Sep;21(9):833-9.

PMID:
9393598
5.

5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.

Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWard AD, West RA, Tibes R, Furge KA, Alberts AS.

Oncogene. 2009 Oct 1;28(39):3429-41. doi: 10.1038/onc.2009.207. Epub 2009 Jul 13. Review.

PMID:
19597464
6.

Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.

Dubourg C, Toutain B, Hélias C, Henry C, Lessard M, Le Gall JY, Le Treut A, Guenet L.

Cancer Genet Cytogenet. 2002 Apr 1;134(1):33-7.

PMID:
11996793
7.

Defining a common region of deletion at 13q21 in human cancers.

Chen C, Brabham WW, Stultz BG, Frierson HF Jr, Barrett JC, Sawyers CL, Isaacs JT, Dong JT.

Genes Chromosomes Cancer. 2001 Aug;31(4):333-44.

PMID:
11433524
8.
9.

Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.

Tokura Y, Shikami M, Miwa H, Watarai M, Sugamura K, Wakabayashi M, Satoh A, Imamura A, Mihara H, Katoh Y, Kita K, Nitta M.

Leuk Res. 2002 Jan;26(1):29-36.

PMID:
11734301
10.

Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.

Hejlik DP, Kottickal LV, Liang H, Fairman J, Davis T, Janecki T, Sexton D, Perry W 3rd, Tavtigian SV, Teng DH, Nagarajan L.

Cancer Res. 1997 Sep 1;57(17):3779-83.

11.

Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.

Jiang Y, Liang H, Guo W, Kottickal LV, Nagarajan L.

Blood. 2000 Jun 15;95(12):3945-50.

12.

Deletions of chromosome 5 in malignant myeloid disorders.

Le Beau MM.

Cancer Surv. 1992;15:143-59. Review.

PMID:
1451109
13.

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, et al.

Science. 1993 Feb 12;259(5097):968-71.

PMID:
8438156
14.

Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.

Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ, Chinault AC, Sever CE, Slovak ML, et al.

Blood. 1994 Jan 1;83(1):199-208.

15.

Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.

MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD.

Genes Chromosomes Cancer. 2004 Nov;41(3):203-13.

PMID:
15334543
16.

Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms.

Castro PD, Liang JC, Nagarajan L.

Blood. 2000 Mar 15;95(6):2138-43.

17.

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA.

Blood. 1992 Mar 15;79(6):1501-10.

18.

Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia.

Faderl S, Gidel C, Kantarjian HM, Manshouri T, Keating M, Albitar M.

Leuk Res. 2001 Jan;25(1):39-43.

PMID:
11137559
19.

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).

Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR.

Oncogene. 2000 Aug 10;19(34):3902-13.

20.

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.

Boultwood J, Fidler C, Lewis S, MacCarthy A, Sheridan H, Kelly S, Oscier D, Buckle VJ, Wainscoat JS.

Blood. 1993 Nov 1;82(9):2611-6.

Supplemental Content

Support Center